Trial
NCT04158674
Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Centre Hospitalier Universitaire Dijon
Collaborators
—
Condition
Acute Decompensated Heart Failure
Intervention
Levosimendan
Why stopped
There was insufficient funding to continue the study in good conditions.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03